Coya Therapeutics, Inc. (COYA) Tops Q1 EPS by 37c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q1 EPS of ($0.32), $0.37 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $251.15 million.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Roku Said To Be In Sale Talks, Including Possible Media Tie-up - Bloomberg
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00